1,082
Views
0
CrossRef citations to date
0
Altmetric
Cardiology & Cardiovascular Disorders

Age shock index and age-modified shock index are valuable bedside prognostic tools for postdischarge mortality in ST-elevation myocardial infarction patients

ORCID Icon, ORCID Icon, , , , , , & ORCID Icon show all
Article: 2311854 | Received 21 Sep 2023, Accepted 25 Jan 2024, Published online: 07 Feb 2024

References

  • GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1–14. doi: 10.1016/S0140-6736(18)32203-7.
  • Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019;4(4):342–352. doi: 10.1001/jamacardio.2019.0295.
  • Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393.
  • Jneid H, Addison D, Bhatt DL, et al. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70(16):2048–2090. doi: 10.1016/j.jacc.2017.06.032.
  • Szummer K, Wallentin L, Lindhagen L, et al. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART Registry 1995–2014. Eur Heart J. 2017;38(41):3056–3065. doi: 10.1093/eurheartj/ehx515.
  • Fan F, Li Y, Zhang Y, et al. Chest pain center accreditation is associated with improved in-hospital outcomes of acute myocardial infarction patients in China: findings from the CCC-ACS project. J Am Heart Assoc. 2019;8(21):e13384.
  • Kostis WJ, Deng Y, Pantazopoulos JS, et al. Trends in mortality of acute myocardial infarction after discharge from the hospital. Circ Cardiovasc Qual Outcomes. 2010;3(6):581–589. doi: 10.1161/CIRCOUTCOMES.110.957803.
  • Huckfeldt P, Escarce J, Sood N, et al. Thirty-day postdischarge mortality among Black and White patients 65 years and older in the Medicare Hospital Readmissions Reduction Program. JAMA Netw Open. 2019;2(3):e190634. doi: 10.1001/jamanetworkopen.2019.0634.
  • Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction, heart failure, and pneumonia. JAMA Netw Open. 2018;1(5):e182777. doi: 10.1001/jamanetworkopen.2018.2777.
  • Rosselló X, Huo Y, Pocock S, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol. 2017;245:27–34. doi: 10.1016/j.ijcard.2017.07.039.
  • Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective Multinational Observational Study (GRACE). BMJ. 2006;333(7578):1091. doi: 10.1136/bmj.38985.646481.55.
  • Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at ­presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031–2037. doi: 10.1161/01.cir.102.17.2031.
  • Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi: 10.1001/jama.2013.184182.
  • Yu T, Tian C, Song J, et al. Age shock index is superior to shock index and modified shock index for predicting long-term prognosis in acute myocardial infarction. Shock. 2017;48(5):545–550. doi: 10.1097/SHK.0000000000000892.
  • Zhou J, Shan PR, Xie QL, et al. Age shock index and age-modified shock index are strong predictors of outcomes in ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention. Coron Artery Dis. 2019;30(6):398–405. doi: 10.1097/MCA.0000000000000759.
  • Zhao L, Du Z, Wu T, et al. Association of the age shock index with coronary plaque characteristics in ST-segment elevation myocardial infarction: a 3-vessel optical coherence tomography study. Catheter Cardiovasc Interv. 2021;97(Suppl. 2):1080–1088. doi: 10.1002/ccd.29652.
  • Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2015;385(9966):441–451. doi: 10.1016/S0140-6736(14)60921-1.
  • Zhang Y, Wang S, Yang S, et al. Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China. BMC Cardiovasc Disord. 2019;19(1):271. doi: 10.1186/s12872-019-1250-9.
  • Zhang Y, Wang S, Cheng Q, et al. Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study. BMJ Open. 2021;11(12):e53510. doi: 10.1136/bmjopen-2021-053510.
  • Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. 2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2019;47:766–783.
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.
  • Pencina MJ, D’ Agostino RBSr., D’ Agostino RBJr., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172. doi: 10.1002/sim.2929.
  • Van Calster B, Wynants L, Verbeek J, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi: 10.1016/j.eururo.2018.08.038.
  • Chaudhry SI, Khan RF, Chen J, et al. National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999–2010. J Am Heart Assoc. 2014;3(5):e1197. doi: 10.1161/JAHA.114.001197.
  • Yamamoto T, Yoshida N, Takayama M, et al. Temporal trends in acute myocardial infarction incidence and mortality between 2006 and 2016 in Tokyo—report from the Tokyo CCU Network. Circ J. 2019;83(6):1405–1409. doi: 10.1253/circj.CJ-19-0187.
  • Song J, Murugiah K, Hu S, et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart. 2020;107(4):313–318. doi: 10.1136/heartjnl-2020-317165.
  • Shang P, Liu GG, Zheng X, et al. Association between medication adherence and 1-year major cardiovascular adverse events after acute myocardial infarction in China. J Am Heart Assoc. 2019;8(9):e11793.
  • Chow CK, Brieger D, Ryan M, et al. Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study. Heart Asia. 2019;11(1):e11122. doi: 10.1136/heartasia-2018-011122.
  • Bordejevic DA, Caruntu F, Mornos C, et al. Prognostic impact of blood pressure and heart rate at admission on in-hospital mortality after primary percutaneous intervention for acute myocardial infarction with ST-segment elevation in Western Romania. Ther Clin Risk Manag. 2017;13:1061–1068. doi: 10.2147/TCRM.S141312.
  • Shen J, Liu G, Yang Y, et al. Prognostic impact of mean heart rate by Holter monitoring on long-term outcome in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Clin Res Cardiol. 2021;110(9):1439–1449. doi: 10.1007/s00392-021-01806-1.
  • Schmitz T, Harmel E, Linseisen J, et al. Shock index and modified shock index are predictors of long-term mortality not only in STEMI but also in NSTEMI patients. Ann Med. 2022;54(1):900–908. doi: 10.1080/07853890.2022.2056240.
  • Chiang CY, Lin CF, Liu PH, et al. Clinical validation of the shock index, modified shock index, delta shock index, and shock index-C for Emergency Department ST-Segment Elevation Myocardial Infarction. J Clin Med. 2022;11(19):5839. doi: 10.3390/jcm11195839.
  • Pramudyo M, Marindani V, Achmad C, et al. Modified shock index as simple clinical independent predictor of in-hospital mortality in acute coronary syndrome patients: a retrospective cohort study. Front Cardiovasc Med. 2022;9:915881. doi: 10.3389/fcvm.2022.915881.
  • Swaminathan RV, Rao SV, McCoy LA, et al. Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2015;65(12):1161–1171. doi: 10.1016/j.jacc.2015.01.028.
  • Lv J, Wang C, Gao X, et al. Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry. BMJ Open. 2023;13(3):e69505. doi: 10.1136/bmjopen-2022-069505.
  • Shiraishi J, Kohno Y, Nakamura T, et al. Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class. Intern Med. 2014;53(9):933–939. doi: 10.2169/internalmedicine.53.1144.
  • Li S, Gao X, Yang J, et al. Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction Registry. BMC Med. 2022;20(1):217. doi: 10.1186/s12916-022-02418-w.
  • Zabojszcz M, Januszek R, Siudak Z, et al. Association between the mortality rate and operator volume in patients undergoing emergency or elective percutaneous coronary interventions. Kardiol Pol. 2020;78(2):138–146. doi: 10.33963/KP.15123.
  • Rakowski T, Węgiel M, Siudak Z, et al. Prevalence and predictors of coronary artery perforation during percutaneous coronary interventions (from the ORPKI National Registry in Poland). Am J Cardiol. 2019;124(8):1186–1189. doi: 10.1016/j.amjcard.2019.07.021.
  • Tokarek T, Dziewierz A, Plens K, et al. Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction. Hellenic J Cardiol. 2021;62(3):212–218. doi: 10.1016/j.hjc.2021.01.011.
  • Khera R, Haimovich J, Hurley NC, et al. Use of machine learning models to predict death after acute myocardial infarction. JAMA Cardiol. 2021;6(6):633–641. doi: 10.1001/jamacardio.2021.0122.
  • Dyrbuś K, Gąsior M, Desperak P, et al. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: analysis of the hyperlipidaemia therapy in tERtiary Cardiological cEnTer (TERCET) registry. Atherosclerosis. 2021;333:16–23. doi: 10.1016/j.atherosclerosis.2021.08.024.
  • Yao J, Xie Y, Liu Y, et al. Prediction factors of 6-month poor prognosis in acute myocardial infarction patients. Front Cardiovasc Med. 2020;7:130. doi: 10.3389/fcvm.2020.00130.